Testing effectiveness (Phase 2)WithdrawnNCT00227773
What this trial is testing
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Carcinoma
Eastern Cooperative Oncology Group